Page last updated: 2024-09-04

rs 2135 and Coronary Thrombosis

rs 2135 has been researched along with Coronary Thrombosis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Itoh, Y; Koike, H; Miyake, S; Mizuno, H; Yorikane, R	1

Other Studies

1 other study(ies) available for rs 2135 and Coronary Thrombosis

Article	Year
Effects of RS-2135, a novel class I antiarrhythmic agent, on sustained ventricular tachycardia after coronary embolization in conscious dogs. Journal of cardiovascular pharmacology, 1994, Volume: 24, Issue:1 Topics: Administration, Oral; Animals; Anti-Arrhythmia Agents; Carbazoles; Coronary Thrombosis; Dogs; Dose-Response Relationship, Drug; Injections, Intravenous; Isoquinolines; Male; Models, Cardiovascular; Myocardial Infarction; Tachycardia, Ventricular	1994

Article

Year

Effects of RS-2135, a novel class I antiarrhythmic agent, on sustained ventricular tachycardia after coronary embolization in conscious dogs.

Journal of cardiovascular pharmacology, 1994, Volume: 24, Issue:1

Topics: Administration, Oral; Animals; Anti-Arrhythmia Agents; Carbazoles; Coronary Thrombosis; Dogs; Dose-Response Relationship, Drug; Injections, Intravenous; Isoquinolines; Male; Models, Cardiovascular; Myocardial Infarction; Tachycardia, Ventricular

1994